Lynn Tidwell Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 929 Meadow Ct, Winchester, VA 22601 Phone: 703-675-0701 |
Shane T Flannery Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 20 E Piccadilly St Ste 11, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 |
Cassidy Babin Physical Therapist Medicare: Medicare Enrolled Practice Location: 20 E Piccadilly St Ste 11&14, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 |
Christopher Anthony Morales, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1808 W Plaza Dr, Winchester, VA 22601 Phone: 540-665-2750 Fax: 540-665-2749 |
Hannah Warpinski Physical Therapist Medicare: Medicare Enrolled Practice Location: 20 E Piccadilly St Ste 11&14, Winchester, VA 22601 Phone: 877-407-3422 Fax: 877-407-4329 |
Gretchen Sue Crowley, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 607 E Jubal Early Dr, Winchester, VA 22601 Phone: 540-536-2328 |
News Archive
USA Today: Doctors are limiting the number of new Medicare patients they are seeing, concerned about reimbursements pay from the federal program. "Recent surveys by national and state medical societies have found more doctors limiting Medicare patients, partly because Congress has failed to stop an automatic 21% cut in payments that doctors already regard as too low.
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva, Switzerland, - working in collaboration with the University of Strasbourg, France, - have identified a molecule that not only greatly reduces the progression of the disease but also boosts life expectancy in animal models by a factor of seven.
Perrigo Company plc today announced that it has entered into an agreement to acquire Naturwohl Pharma GmbH with its leading German dietary supplement brand, Yokebe. The brand is expected to generate approximately €30 million in full year 2015 net sales.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient SGX94 for the treatment of acute radiation syndrome (ARS).
The primitive stem cell state we created is called an "induced pluripotent stem cell" (iPSC). iPSC are a new, unique, and artificially-created type of stem cell that were first described in 2006 by a Japanese scientist named Shinya Yamanaka.
› Verified 6 days ago